首页 产品目录 分子砌块 按反应类型 1,2,4-三唑 (5S,8S,14S,17S,20S,26S,29S,32S,35S,41S,44S,50S,53S,56S)-41-((1H-吲哚-3-基)甲基)-35-(2-氨基-2-氧代乙基)-8,26-二苄基-17,29,53-三((S)-仲丁基)-32,44-双(2-羧乙基)-56-((6S,9S,12S,15S,18S,21S,24S,27S,30S)-1,6-二氨基-15-(3-氨基-3-氧代丙基)-24,27-双(4-氨基丁基)-9,12,18,21,30-五(3-胍基丙基)-1-亚胍基-7,10,13,16,19,22,25,28,31,34-十氧代-2,8,11,14,17,20,23,26,29,32,35-十一氮杂庚三十七烷-37-酰胺基)-5-异丁基-14,20-二甲基-50-(2-(甲硫基)乙基)-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55-十八氧代-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54-十八氮杂八五十八烷二酸

(5S,8S,14S,17S,20S,26S,29S,32S,35S,41S,44S,50S,53S,56S)-41-((1H-吲哚-3-基)甲基)-35-(2-氨基-2-氧代乙基)-8,26-二苄基-17,29,53-三((S)-仲丁基)-32,44-双(2-羧乙基)-56-((6S,9S,12S,15S,18S,21S,24S,27S,30S)-1,6-二氨基-15-(3-氨基-3-氧代丙基)-24,27-双(4-氨基丁基)-9,12,18,21,30-五(3-胍基丙基)-1-亚胍基-7,10,13,16,19,22,25,28,31,34-十氧代-2,8,11,14,17,20,23,26,29,32,35-十一氮杂庚三十七烷-37-酰胺基)-5-异丁基-14,20-二甲基-50-(2-(甲硫基)乙基)-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55-十八氧代-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54-十八氮杂八五十八烷二酸

(5S,8S,14S,17S,20S,26S,29S,32S,35S,41S,44S,50S,53S,56S)-41-((1H-indol-3-yl)methyl)-35-(2-amino-2-oxoethyl)-8,26-dibenzyl-17,29,53-tri((S)-sec-butyl)-32,44-bis(2-carboxyethyl)-56-((6S,9S,12S,15S,18S,21S,24S,27S,30S)-1,6-diamino-15-(3-amino-3-oxopropyl)-24,27-bis(4-aminobutyl)-9,12,18,21,30-pentakis(3-guanidinopropyl)-1-imino-7,10,13,16,19,22,25,28,31,34-decaoxo-2,8,11,14,17,20,23,26,29,32,35-undecaazaheptatriacontan-37-amido)-5-isobutyl-14,20-dimethyl-50-(2-(methylthio)ethyl)-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55-octadecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54-octadecaazaoctapentacontanedioic acid

产品编号 :
Cas No. :
包装规格 纯度 目录价 会员专享价 库存 数量

抱歉,暂无牌价信息

晶智化学产品均仅供科研使用。在任何情况下,我们均不提供用于动物或人体用途的产品或服务。

基础信息

CAS No.

923954-79-4

中文名称

(5S,8S,14S,17S,20S,26S,29S,32S,35S,41S,44S,50S,53S,56S)-41-((1H-吲哚-3-基)甲基)-35-(2-氨基-2-氧代乙基)-8,26-二苄基-17,29,53-三((S)-仲丁基)-32,44-双(2-羧乙基)-56-((6S,9S,12S,15S,18S,21S,24S,27S,30S)-1,6-二氨基-15-(3-氨基-3-氧代丙基)-24,27-双(4-氨基丁基)-9,12,18,21,30-五(3-胍基丙基)-1-亚胍基-7,10,13,16,19,22,25,28,31,34-十氧代-2,8,11,14,17,20,23,26,29,32,35-十一氮杂庚三十七烷-37-酰胺基)-5-异丁基-14,20-二甲基-50-(2-(甲硫基)乙基)-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55-十八氧代-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54-十八氮杂八五十八烷二酸

英文名称

(5S,8S,14S,17S,20S,26S,29S,32S,35S,41S,44S,50S,53S,56S)-41-((1H-indol-3-yl)methyl)-35-(2-amino-2-oxoethyl)-8,26-dibenzyl-17,29,53-tri((S)-sec-butyl)-32,44-bis(2-carboxyethyl)-56-((6S,9S,12S,15S,18S,21S,24S,27S,30S)-1,6-diamino-15-(3-amino-3-oxopropyl)-24,27-bis(4-aminobutyl)-9,12,18,21,30-pentakis(3-guanidinopropyl)-1-imino-7,10,13,16,19,22,25,28,31,34-decaoxo-2,8,11,14,17,20,23,26,29,32,35-undecaazaheptatriacontan-37-amido)-5-isobutyl-14,20-dimethyl-50-(2-(methylthio)ethyl)-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55-octadecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54-octadecaazaoctapentacontanedioic acid

别名

Glycine, L-arginyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-lysyl-L-lysyl-L-arginylglycylglycyl-L-α-aspartyl-L-isoleucyl-L-methionylglycyl-L-α-glutamyl-L-tryptophylglycyl-L-asparaginyl-L-α-glutamyl-L-isoleucyl-L-phenylalanylglycyl-L-alanyl-L-isoleucyl-L-alanylglycyl-L-phenylalanyl-L-leucyl-;Glycine, L-arginyl-L-arginyl-L-arginyl-L-glutaminyl-L-arginyl-L-arginyl-L-lysyl-L-lysyl-L-arginylglycylglycyl-L-α-aspartyl-L-isoleucyl-L-methionylglycyl-L-α-glutamyl-L-tryptophylglycyl-L-asparaginyl-L-α-glutamyl-L-isoleucyl-L-phenylalanylglycyl-L-alanyl-L-isoleucyl-L-alanylglycyl-L-phenylalanyl-L-le...

标准英文名

(5S,8S,14S,17S,20S,26S,29S,32S,35S,41S,44S,50S,53S,56S)-41-((1H-indol-3-yl)methyl)-35-(2-amino-2-oxoethyl)-8,26-dibenzyl-17,29,53-tri((S)-sec-butyl)-32,44-bis(2-carboxyethyl)-56-((6S,9S,12S,15S,18S,21S,24S,27S,30S)-1,6-diamino-15-(3-amino-3-oxopropyl)-24,27-bis(4-aminobutyl)-9,12,18,21,30-pentakis(3-guanidinopropyl)-1-imino-7,10,13,16,19,22,25,28,31,34-decaoxo-2,8,11,14,17,20,23,26,29,32,35-undecaazaheptatriacontan-37-amido)-5-isobutyl-14,20-dimethyl-50-(2-(methylthio)ethyl)-4,7,10,13,16,19,22,25,28,31,34,37,40,43,46,49,52,55-octadecaoxo-3,6,9,12,15,18,21,24,27,30,33,36,39,42,45,48,51,54-octadecaazaoctapentacontanedioic acid

分子式

C149H243N53O39S

分子量

3432.98

精确分子量

3430.84

SMILES

CC[C@H](C)[C@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CCC(=O)O)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O

标准SMILES

CC(C)C[C@H](NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)CNC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC1=CNC2=CC=CC=C12)NC(=O)[C@H](CCC(O)=O)NC(=O)CNC(=O)[C@H](CCSC)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CCCNC(N)=N)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)CC)C(=O)NCC(O)=O

用途

TAT-HA2 Fusion Peptide is a peptide-based delivery agent that combines the pH-sensitive HA2 fusion peptide from Influenza and the cell-penetrating peptide TAT from HIV; it functions as a trans-activator of transcription and hemagglutinin for endosomal release and enhances cellular uptake of macromolecules.

InChIKey

HKDRFTFEDPBOGG-XUHOUDFZSA-N

安全信息

SureRoute逆合成路线

1.  923954-79-4 逆合成路线 1

—
—
ACRHMH464
923954-79-4
来源: SureRoute

2.  923954-79-4 逆合成路线 2

—
—
ACRHMH464
923954-79-4
来源: SureRoute

3.  923954-79-4 逆合成路线 3

—
—
ACRHMH464
923954-79-4
来源: SureRoute
评论 0
我是晶智Agent,
您的化学小助手